Literature DB >> 29165020

Preliminary Outcomes From a Community-Based Elder Abuse Risk and Evaluation Tool.

Jason Dauenhauer1, Kristin Heffernan1, Paul L Caccamise2, Allison Granata2, Lindsay Calamia2, Tracey Siebert-Konopko2, Art Mason2.   

Abstract

This research addresses the need to develop an assessment tool for case workers working in the aging services field outside of APS. As such, the research discusses the development, implementation, and preliminary outcomes of the Elder Abuse Risk Assessment and Evaluation© tool (EARAE). This instrument was developed and pilot tested by the Elder Abuse Prevention Program (EAPP), a program within Lifespan of Greater Rochester Inc. in Rochester, New York. A total of 189 suspected elder mistreatment cases were investigated using the EARAE instrument to track elements at the start and close of each case. Results indicate the tool represents an effective way to capture abuse indicators, track contributing risk factors, measure multiple case outcomes, and track types of interventions utilized. Opportunities and limitations of the tool are also discussed.

Keywords:  elder abuse; measure development; program outcomes; risk assessment

Year:  2017        PMID: 29165020     DOI: 10.1177/0733464817733105

Source DB:  PubMed          Journal:  J Appl Gerontol        ISSN: 0733-4648


  3 in total

1.  Elder Mistreatment Victims during the COVID-19 Pandemic: Administrative Data from San Francisco Adult Protective Services.

Authors:  Pi-Ju Liu; Aining Wang; Laura M Schwab-Reese; Sara K Stratton
Journal:  J Fam Violence       Date:  2021-08-14

2.  Examining Adult Protective Services Outcomes: Services Associated With the Decrease of Mistreatment Differed by Elder Mistreatment Type.

Authors:  Pi-Ju Liu; Zachary Hass; Sara K Stratton; Karen M Conrad; Kendon J Conrad
Journal:  Gerontologist       Date:  2022-10-19

3.  Elder Abuse Assessment Tools and Interventions for use in the Home Environment: a Scoping Review.

Authors:  Kathleen Van Royen; Paul Van Royen; Liesbeth De Donder; Robbert J Gobbens
Journal:  Clin Interv Aging       Date:  2020-09-28       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.